STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Crypto Bitcoin
bitcoin-1

MicroStrategy Reports $561M Share Sale and Expands Bitcoin Holdings

byLuca Blaumann
December 23, 2024
in Bitcoin, Large-Cap, Software
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

Significant Bitcoin Acquisition and Strong BTC Yield Mark Strategic Moves

On December 23, 2024, MicroStrategy (MSTR) provided updates on its share sales and bitcoin holdings, reflecting its continued strategic focus on leveraging capital markets to expand cryptocurrency investments.

Share Sale Raises $561 Million

Between December 16 and December 22, 2024, MicroStrategy sold approximately 1.32 million shares under its existing Sales Agreement, generating net proceeds of around $561 million after accounting for sales commissions. As of December 22, approximately $7.08 billion worth of shares remained available for issuance and sale under the agreement.

This successful capital raise highlights MicroStrategy’s ability to attract investors and efficiently utilize its equity to fund strategic initiatives.

Significant Bitcoin Acquisition at Record Prices

During the same period, MicroStrategy utilized the $561 million raised to purchase 5,262 bitcoins at an average price of $106,662 per bitcoin, inclusive of fees and expenses. This marks one of MicroStrategy’s most significant acquisitions of the digital asset to date, aligning with its aggressive accumulation strategy.

As of December 22, 2024, MicroStrategy and its subsidiaries held a total of 444,262 bitcoins. These holdings were acquired at an aggregate cost of approximately $27.7 billion, with an average purchase price of $62,257 per bitcoin, inclusive of fees and expenses.

Strong BTC Yield Highlights Strategic Success

MicroStrategy also reported its BTC Yield, a key performance indicator (KPI) that measures the percentage change in the ratio of bitcoin holdings to Assumed Diluted Shares Outstanding over specific periods.

From October 1 to December 22, 2024, MicroStrategy achieved a BTC Yield of 47.4%, while the year-to-date figure stood at an impressive 73.7%. This metric underscores MicroStrategy’s strategy of acquiring bitcoin in a manner it believes is accretive to shareholders.

BTC Yield considers both the growth in bitcoin holdings and the impact of share dilution, offering investors insight into the effectiveness of MicroStrategy’s approach to funding cryptocurrency purchases through share issuance or convertible instruments.

Positioning for Long-Term Value

MicroStrategy’s actions reflect a deliberate strategy to maximize the value of its bitcoin holdings while maintaining shareholder interests. The ability to raise substantial funds through share sales and deploy them effectively into bitcoin acquisitions highlights the company’s confidence in the digital asset’s long-term potential.

As cryptocurrency markets continue to evolve, MicroStrategy’s growing bitcoin reserves and strong BTC Yield position it as a key player in the intersection of traditional capital markets and digital assets, reinforcing its commitment to driving shareholder value through strategic investments.

You might like this article:Telomir Pharmaceuticals Advances Groundbreaking Research in Copper-Binding Therapies for Wilson’s Disease

Tags: bitcoinGrowthMicroStrategyMoversMSTRNewsStock Market
Previous Post

Telomir Pharmaceuticals Advances Groundbreaking Research in Copper-Binding Therapies for Wilson’s Disease

Next Post

Traws Pharma Advances Bird Flu Treatment with Promising Phase 1 Results

Related Posts

Casual Dining’s Comeback: Why Sit-Down Chains Are Beating Fast Casual

byLuca Blaumann
August 21, 2025
0

Affordable deals and smart upgrades are drawing value-seeking consumers back to the table As inflation pressures household budgets and economic...

Intel Seeks More Equity Infusions Amid Mounting Financial Strains

byLuca Blaumann
August 20, 2025
0

Talks with new investors follow SoftBank’s $2 billion stake as pressure builds on turnaround plan Intel (INTC) is in discussions...

Intel Shares Surge After $2 Billion SoftBank Investment

byLuca Blaumann
August 19, 2025
0

Japanese conglomerate’s backing boosts confidence in chipmaker’s turnaround efforts Intel (INTC) shares jumped more than 9% on Tuesday after SoftBank...

Next Post
chemistry-2

Traws Pharma Advances Bird Flu Treatment with Promising Phase 1 Results

Latest News

Casual Dining’s Comeback: Why Sit-Down Chains Are Beating Fast Casual

Intel Seeks More Equity Infusions Amid Mounting Financial Strains

Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial

Intel Shares Surge After $2 Billion SoftBank Investment

Strategy Expands Bitcoin Holdings With $51 Million Purchase

Based on Your Interest

Aerospace & Defense

Amphenol Expands Defense Portfolio With $1 Billion Trexon Acquisition

August 18, 2025
investing
Insurance

Buffett Bet Sends UnitedHealth Shares Soaring

August 18, 2025
Small-Cap

KULR Technology Group Reports Record Q2 Revenue and Expands Bitcoin Treasury Holdings

August 14, 2025

Recommended

Financial Services

Berkshire Hathaway Adds New Stakes Across Healthcare, Industrials, and Real Estate

August 14, 2025
Pharmaceuticals

Eli Lilly Strikes $1.3 Billion Deal with Superluminal Medicines to Advance AI-Driven Obesity Drug Development

August 14, 2025
Large-Cap

Ulta and Target to End Mini-Store Partnership in 2026

August 14, 2025
Airlines

Spirit Aviation Warns of Possible Collapse as Cash Runs Low

August 13, 2025
Large-Cap

Cava Shares Plunge as Chain Cuts Same-Store Sales Outlook

August 12, 2025
Stoxpo

Follow us on social media:

Highlights

  • Casual Dining’s Comeback: Why Sit-Down Chains Are Beating Fast Casual
  • Intel Seeks More Equity Infusions Amid Mounting Financial Strains
  • Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial
  • Intel Shares Surge After $2 Billion SoftBank Investment
  • Strategy Expands Bitcoin Holdings With $51 Million Purchase

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Casual Dining’s Comeback: Why Sit-Down Chains Are Beating Fast Casual

August 21, 2025

Intel Seeks More Equity Infusions Amid Mounting Financial Strains

August 20, 2025
scientist

Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial

August 19, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?